The influence of COVID-19 on PD is largely unknown and elucidating the impact of SARS-CoV-2 on PD has a large potential for understanding the risk SARS-CoV-2 infection poses with respect to acceleration of subclinical PD and to understand prognosis of PD. In this project, the team will map relevant inflammatory biological pathways relevant to PD and Covid-19.